Dr Carolyn Staton

PhD, MBiochem, SFHEA

School of Medicine and Population Health

Senior Lecturer in Medical Education

c.a.staton@sheffield.ac.uk
+44 114 222 3609
The Medical School

Full contact details

Dr Carolyn Staton
School of Medicine and Population Health
The Medical School
Beech Hill Road
Sheffield
S10 2RX
Profile

I joined the University in 1997 as a PhD student. During the course of my PhD, I discovered a number of novel anti-angiogenic agents which were patented by the ±¬ÁÏTV.

In 2002 I became a guest lecturer on an intercalated BSc in UCL, teaching cancer biology & angiogenesis.

In 2004 I was appointed to a lectureship and started teaching on the MBChB course and on cancer biology in MBB.  I was awarded the Certificate in Learning and Teaching in 2009. 

In 2013 I designed and established the MSc(Res) in Translational Oncology and ran this until 2021. In 2016 I became a Senior Fellow of the Higher Education Academy and Senior Lecturer. 

I was the departmental director of learning and teaching for the Department of Oncology & Metabolism from 2018-2021.

In 2018 I was appointed to become the Director of Intercalation and started running the BSc in Medical Sciences Research course for intercalating medical students. 

In 2021 I moved to the section of Medical Education, where I am now the Deputy Director of Student Support, the director of the Academic Tutoring scheme, the disability liaison officer for MBChB students, History of Medicine and Critical Analysis Student Selected Component leads and teach biochemistry to first year students. I am also a member of the University Discipline Committee.

Research interests

My current research interests are student perceptions and decision-making processes around intercalation, and the challenge of choice within the medical school curriculum. 

Collaborative research with colleagues in Sheffield also includes investigations into incidentaloma in modern medicine, the challenges and potential solutions.

Publications

Show: Featured publications All publications

Journal articles

  • Cole-Healy Z, Vergani P, Hunter K, Brown NJ, Reed MWR & Staton CA (2015) . Experimental and Molecular Pathology, 99(1), 19-24.
  • Young RJ, Woll PJ, Staton CA, Reed MWR & Brown NJ (2014) . Cancer Chemother Pharmacol, 73(2), 259-270.
  • Staton CA, Koay I, Wu JM, Hoh L, Reed MWR & Brown NJ (2013) . Histopathology, 62(6), 908-915.
  • Mackinder MA, Evans CA, Chowdry J, Staton CA & Corfe BM (2012) . Cancer Biomark, 12(2), 49-64.
  • Wu JM & Staton CA (2012) . Expert Opin Drug Discov, 7(8), 723-743.
  • Wild JRL, Staton CA, Chapple K & Corfe BM (2012) . Int J Exp Pathol, 93(2), 81-103.
  • Hsu Y-P, Staton CA, Cross N & Buttle DJ (2012) . Int J Exp Pathol, 93(1), 70-77.
  • Valluru M, Staton CA, Reed MWR & Brown NJ (2011) . Front Physiol, 2, 89.
  • Staton CA, Shaw LA, Valluru M, Hoh L, Koay I, Cross SS, Reed MW & Brown NJ (2011) . Histopathology, 59(2), 274-282.
  • Valluru M, Brown NJ, Cross SS, Reed MWR & Staton CA (2011) . Br J Dermatol, 165(1), 221-224.
  • Yu DCW, Bury JP, Tiernan J, Waby JS, Staton CA & Corfe BM (2011) . Mol Cancer, 10, 27.
  • Bluff JE, Amarzguioui M, Slattery J, Reed MWR, Brown NJ & Staton CA (2011) . Breast Cancer Res Treat, 128(3), 691-701.
  • Yu DCW, Waby JS, Chirakkal H, Staton CA & Corfe BM (2010) . Mol Cancer, 9, 276.
  • Staton CA, Valluru M, Hoh L, Reed MWR & Brown NJ (2010) . Br J Dermatol, 163(5), 920-927.
  • Kumar I, Staton CA, Cross SS, Reed MWR & Brown NJ (2009) . Br J Surg, 96(12), 1484-1491.
  • Bluff JE, Menakuru SR, Cross SS, Higham SE, Balasubramanian SP, Brown NJ, Reed MW & Staton CA (2009) . Br J Cancer, 101(4), 666-672.
  • Staton CA, Reed MWR & Brown NJ (2009) . Int J Exp Pathol, 90(3), 195-221.

All publications

Books

  • Staton C, Lewis CE & Bicknell R (2007) Angiogenesis Assays: A Critical Appraisal of Current Techniques. Wiley-Blackwell.

Journal articles

  • Lim JJ, Roberts C, Graham O, Coady S, Topliss J & Staton C (2025) . BMC Medical Education, 25.
  • Kapoore RV, Coyle R, Staton CA, Brown NJ & Vaidyanathan S (2015) . Metabolomics, 11(6), 1743-1755.
  • Cole-Healy Z, Vergani P, Hunter K, Brown NJ, Reed MWR & Staton CA (2015) . Experimental and Molecular Pathology, 99(1), 19-24.
  • Young RJ, Woll PJ, Staton CA, Reed MWR & Brown NJ (2014) . Cancer Chemother Pharmacol, 73(2), 259-270.
  • Wild J, Gunarwardene A, Staton C, Chapple K & Corfe B (2013) . International Journal of Surgery, 11(8), 600-600.
  • Narramore R, Wild J, Corfe B, Staton C, Yu D & Chapple K (2013) . International Journal of Surgery, 11(8), 624-624.
  • Staton CA, Koay I, Wu JM, Hoh L, Reed MWR & Brown NJ (2013) . Histopathology, 62(6), 908-915.
  • Mackinder MA, Evans CA, Chowdry J, Staton CA & Corfe BM (2012) . Cancer Biomark, 12(2), 49-64.
  • Wu JM & Staton CA (2012) . Expert Opin Drug Discov, 7(8), 723-743.
  • Wild JRL, Staton CA, Chapple K & Corfe BM (2012) . Int J Exp Pathol, 93(2), 81-103.
  • Hsu Y-P, Staton CA, Cross N & Buttle DJ (2012) . Int J Exp Pathol, 93(1), 70-77.
  • Valluru M, Staton CA, Reed MWR & Brown NJ (2011) . Front Physiol, 2, 89.
  • Staton CA (2011) . Biochem Soc Trans, 39(6), 1565-1570.
  • Staton CA, Hoh L, Baldwin A, Shaw L, Globe J, Cross SS, Reed MW & Brown NJ (2011) . Histopathology, 59(2), 256-263.
  • Staton CA, Shaw LA, Valluru M, Hoh L, Koay I, Cross SS, Reed MW & Brown NJ (2011) . Histopathology, 59(2), 274-282.
  • Valluru M, Brown NJ, Cross SS, Reed MWR & Staton CA (2011) . Br J Dermatol, 165(1), 221-224.
  • Young RJ, Brown NJ, Staton CA, Reed MW & Woll PJ (2011) Functional studies in two angiosarcoma cell lines.. J Clin Oncol, 29(15_suppl), e20511.
  • Gunawardene AR, Corfe BM & Staton CA (2011) . Int J Exp Pathol, 92(4), 219-231.
  • Yu DCW, Bury JP, Tiernan J, Waby JS, Staton CA & Corfe BM (2011) . Mol Cancer, 10, 27.
  • Bluff JE, Amarzguioui M, Slattery J, Reed MWR, Brown NJ & Staton CA (2011) . Breast Cancer Res Treat, 128(3), 691-701.
  • Krajewska E, Lewis C, Staton C, MacGowan A & MacNeil S (2011) . J Tissue Eng Regen Med, 5(5), 363-374.
  • Yu DCW, Waby JS, Chirakkal H, Staton CA & Corfe BM (2010) . Mol Cancer, 9, 276.
  • Staton CA, Valluru M, Hoh L, Reed MWR & Brown NJ (2010) . Br J Dermatol, 163(5), 920-927.
  • Krajewska E, Lewis CE, Chen Y-Y, Welford A, Tazzyman S & Staton CA (2010) . Br J Cancer, 102(3), 594-601.
  • Kumar I, Staton CA, Cross SS, Reed MWR & Brown NJ (2009) . Br J Surg, 96(12), 1484-1491.
  • Staton CA, Brown NJ & Reed MWR (2009) . EXPERT OPIN DRUG DIS, 4(9), 961-979.
  • Bluff JE, Menakuru SR, Cross SS, Higham SE, Balasubramanian SP, Brown NJ, Reed MW & Staton CA (2009) . Br J Cancer, 101(4), 666-672.
  • Staton CA, Reed MWR & Brown NJ (2009) . Int J Exp Pathol, 90(3), 195-221.
  • Menakuru SR, Brown NJ, Staton CA & Reed MWR (2008) . Br J Cancer, 99(12), 1961-1966.
  • Kumar I, Balasubraminian S, Staton C, Brown N & Reed M (2008) . European Journal of Surgical Oncology (EJSO), 34(10), 1194-1194.
  • Bluff JE, Brown NJ, Reed MWR & Staton CA (2008) . Breast Cancer Res, 10(2), 204.
  • Staton CA, Lewis C & Bicknell R (2007) . Angiogenesis Assays A Critical Appraisal of Current Techniques, xv-xvi.
  • Staton CA, Chetwood ASA, Cameron IC, Cross SS, Brown NJ & Reed MWR (2007) . Gut, 56(10), 1426-1432.
  • Staton CA, Kumar I, Reed MWR & Brown NJ (2007) . J Pathol, 212(3), 237-248.
  • Staton CA, Stribbling SM, García-Echeverría C, Bury JP, Tazzyman S, Lewis CE & Brown NJ (2007) . J Thromb Haemost, 5(4), 846-854.
  • Staton CA & Lewis CE (2005) . J Cell Mol Med, 9(2), 286-302.
  • Staton CA, Stribbling SM, Tazzyman S, Hughes R, Brown NJ & Lewis CE (2004) . Int J Exp Pathol, 85(5), 233-248.
  • Staton CA, Brown NJ, Rodgers G, Corke KP, Tazzyman S, Underwood JCE & Lewis CE (2004) . Microcirculation, 11(6), 531-532.
  • Staton CA, Brown NJ, Rodgers GR, Corke KP, Tazzyman S, Underwood JCE & Lewis CE (2004) . Blood, 103(2), 601-606.
  • Staton CA, Brown NJ & Lewis CE (2003) . Expert Opin Biol Ther, 3(7), 1105-1120.
  • Brown NJ, Staton CA, Rodgers GR, Corke KP, Underwood JCE & Lewis CE (2002) . Br J Cancer, 86(11), 1813-1816.
  • Bootle-Wilbraham CA, Tazzyman S, Thompson WD, Stirk CM & Lewis CE (2001) . Angiogenesis, 4(4), 269-275.
  • Bootle-Wilbraham CA, Tazzyman S, Marshall JM & Lewis CE (2000) Fibrinogen E-fragment inhibits the migration and tubule formation of human dermal microvascular endothelial cells in vitro.. Cancer Res, 60(17), 4719-4724.
  • Jeziore-Sassoon Y, Hamblin PA, Bootle-Wilbraham CA, Poole PS & Armitage JP (1998) . Microbiology (Reading), 144 ( Pt 1), 229-239.
  • Staton CA, Jeziore-Sassoon Y, Hamblin PA, Poole PS & Armitage JP (1998) Metabolism is required for chemotaxis in response to sugars in Rhodobacter sphaeroides. Microbiology, 144(1), 229-239.
  • Kapoore RV, Coyle R, Staton CA, Brown NJ & Vaidyanathan S () . Analyst, 11, 2038-2049.

Book chapters

  • Staton CA & Smith EJ (2006) Tubule Formation Assays In Staton C, Lewis CE & Bicknell R (Ed.), Angiogenesis Assays: A Critical Appraisal of Current Techniques (pp. 65-88). Wiley-Blackwell
  • Staton CA & Lewis CE (2006) Alphastatin: a pluripotent inhibitor of activated endothelial cells In Siemann DW (Ed.), Vascular-targeted therapies in oncology (pp. 205-220). Wiley-Blackwell
  • Staton CA & Lewis CE (2005) Haemostatic Regulators as drug targets in tumour angiogenesis In Weber GF (Ed.), Cancer therapy (pp. 187-220). Taylor & Francis
  • Staton CA, Brown NJ & Lewis CE (2004) Effects of fibrinogen and associated peptide fragments on the activation of human endothelial cells by VEGF in vitro In Harmey JH (Ed.), VEGF and Cancer (pp. 117-132). Springer

Conference proceedings

  • Wild JRL, Staton CA, Chapple KS & Corfe BM (2013) Comparison and Optimisation of a strategy to isolate a single cell population of epithelial cells from the crypt compartment of the murine colon. BRITISH JOURNAL OF SURGERY, Vol. 100 (pp 99-99)
  • Wild JRL, Gunawardene AR, Staton CA, Chapple KS & Corfe BM (2013) Neuropilin-1 expression in the normal colon is enteroendocrine-like. BRITISH JOURNAL OF SURGERY, Vol. 100 (pp 123-123)
  • Bury JP, Riley S, Evans CA, Williams EA, Staton CA, Murabito E, Smallbone K & Corfe BM (2012) Why do Patients get Metachronous Colorectal Adenomas?. JOURNAL OF PATHOLOGY, Vol. 228 (pp S3-S3)
  • Wild JRL, Khan AQ, Li NX, Staton C, Chapple K & Corfe BM (2012) Neuropilin-1: A predictor of early carcinogenesis in the colonic epithelium. BRITISH JOURNAL OF SURGERY, Vol. 99 (pp 24-24)
  • Khan AQ, Wild J, Nai X, Brown S, Staton C, Brown S & Corfe B (2012) Faecal butyrate levels have different effect on cancer and adenoma tissues: Suggestion of early beneficial role of butyrate during carcinogenesis. BRITISH JOURNAL OF SURGERY, Vol. 99 (pp 29-29)
  • Young R, Woll PJ, Staton CA, Reed MW & Brown NJ (2011) Targeting VEGF in Human Angiosarcoma Cell Lines in Vitro. EUROPEAN JOURNAL OF CANCER, Vol. 47 (pp S665-S665)
  • Young RJ, Tin A, Brown NJ, Staton C, Lee SM, Jital M & Woll P (2011) SERUM BIOMARKERS IN LUNG CANCER PATIENTS FROM TWO CLINICAL TRIALS OF CHEMOTHERAPY WITH OR WITHOUT THALIDOMIDE. J THORAC ONCOL, Vol. 6(6) (pp S1058-S1059)
  • Young RJ, Brown NJ, Staton CA, Reed MW & Woll PJ (2011) . JOURNAL OF CLINICAL ONCOLOGY, Vol. 29(15)
  • Lunj S, Staton CA, Holen I, Ballmer-Hofer K, Reed MW & Brown NJ (2011) . Cancer Research, Vol. 71(8_Supplement) (pp 5131-5131)
  • Hsu YP, Staton CA & Buttle DJ (2010) ADAMTS-4 may regulate VEGF-stimulated angiogenesis. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, Vol. 91(6) (pp A32-A33)
  • Hsu YP, Staton CA & Buttle DJ (2010) Molecular interactions of ADAMTS-4 in the VEGFR2 signalling complex. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, Vol. 91(2) (pp A30-A30)
  • Hsu YP, Staton CA & Buttle DJ (2009) The molecular interactions involved in VEGF-induced signalling pathways. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, Vol. 90(2) (pp A114-A114)
  • Bluff JE, Cross SS, Brown NJ, Reed MW & Staton CA (2008) . BREAST CANCER RESEARCH, Vol. 10 (pp S24-S24)
  • Staton CA, Yang Z, Reed MWR & Brown NJ (2008) . BREAST CANCER RESEARCH, Vol. 10 (pp S38-S38)

Preprints

  • Lim JJ, Roberts C, Graham O, Coady S, Topliss J & Staton C (2024) , Springer Science and Business Media LLC.
Teaching interests

I am passionate about student support and welfare and am the Deputy Director of Student Support for the MBChB and PA courses and am also the Disability Liaison Officer for MBChB students and head up the Academic Tutor scheme for these students. 

I run the intercalation course and the first two student selected components and am passionate about seeing medical students develop their skills in academic research and enhance their CVs for future job applications. 

I am an academic tutor and/or mentor for undergraduate medical students, PGT and PGR students in the Medical school and was nominated for Best Academic Mentor in the Annual Academic Awards 2018.

Teaching activities
  • Director of Intercalation
  • BSc Medical Sciences Research course lead
  • History of Medicine student selected component lead
  • Critical analysis student selected component lead
  • First year Biochemistry teaching for MBChB students
  • Tumour Microenvironment and Cancer Immunology Module co-lead
  • Admissions – interviews for MBChB course
  • Assessment MBChB – marking student selected components throughout the 5 year MBChB course; setting, quality assurance, standard setting and marking first year exams, Quality assurance for OSCEs
  • Assessment PGT/BSc– setting and marking assignments for different modules on the PGT and intercalated BSc courses
  • Student support
  • Curriculum design
Professional activities and memberships
  • Senior Fellow of the Higher Education Academy
  • Director of Intercalated Studies
  • Deputy Director of Student Experience & Support (MBChB)
  • Disability Liaison Officer for Medical School MBChB
  • Academic Lead – BSc Medical Sciences Research
  • Academic Lead – History of Medicine SSC
  • Academic Lead – Critical Analysis SSC
  • Director of the Academic Tutor scheme for MBChB
  • External Examiner at the University of Nottingham & Hull (2023 – present)
  • Honorary Treasurer – British Microcirculation Society (2016 – 2021)